Bristol-Myers Squibb buy StockNews.com
Start price
29.07.23
/
50%
€55.90
Target price
29.07.24
-
Performance (%)
-19.63%
End price
30.07.24
€44.93
Summary
This prediction ended on 30.07.24 with a price of €44.93. The price of Bristol-Myers Squibb has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.63%. StockNews_com has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. A total of €2.19 was paid as dividends for this prediction. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | -0.018% | -0.018% | 35.402% | -1.804% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% | 64.061% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% | 86.918% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% | 77.872% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% | 68.192% |
Comments by StockNews_com for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten